Chembio Diagn (CEMI) Tops Q2 EPS by 1c
Tweet Send to a FriendGet Alerts CEMI Hot Sheet
Trade CEMI Now!
Chembio Diagn (NASDAQ: CEMI) reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $6.08 million versus the consensus estimate of $6.36 million.
For earnings history and earnings-related data on Chembio Diagn (CEMI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Chembio Diagn (CEMI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Chembio's SURE CHECK(R) HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV Receives CE Mark Approval
- UPDATE: Citi Raises PT on Micron Technology (MU) to $19
- China Cord Blood Corp. (CO) Tops Q4 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
